Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease

American Journal of Neuroradiology

Volumn 31, Issue 5, 2010, Pages 847-855

  Raji, Cyrus A ^a   Lee, C ^b   Lopez, O L ^a   Tsay, J ^a   Boardman, J F ^a   Schwartz, E D ^d   Bartynski, W S ^a   Hefzy, H M ^c   Gach, H M ^a,e,f   Dai, W ^g   Becker, J T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d Shields MRI Health Care Group   (United States)

^e UNIVERSITY OF NEVADA   (United States)

^f UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; COGNITION; CONTINUOUS ARTERIAL SPIN LABELED MAGNETIC RESONANCE IMAGING; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; FRONTAL LOBE; HUMAN; INSTITUTIONAL REVIEW; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PERFUSION WEIGHTED IMAGING; RELIABILITY; SENSITIVITY AND SPECIFICITY; SPOILED GRADIENT RECALLED ECHOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CEREBRAL ARTERIES; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPIN LABELS;

EID: 77952348701     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1955     Document Type: Article

References (65)

1. Sloane PD, Zimmerman S, Suchindran C, et al. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health 2002;23:213-231
2. Frisoni GB, Testa C, Sabattoli F, et al. Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry 2005;76:112-114
3. Ohnishi T, Matsuda H, Tabira T, et al. Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process? AJNR Am J Neuroradiol 2001;22:1680-1685
4. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review) - report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-1153
5. Karas GB, Burton EJ, Rombouts SA, et al. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 2003;18:895-907
6. Silverman DH, Small GW, Chang CY, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 2001;286:2120-2127
7. Jagust WJ, Johnson KA, Holman BL. SPECT perfusion imaging in the diagnosis of dementia. J Neuroimaging 1995;5:S45-S52
8. Detre JA, Leigh JS, Williams DS, et al. Perfusion imaging. Magn Reson Med 1992;23:37-45
9. Detre JA, Alsop DC, Vives LR, et al. Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease. Neurology 1998;50:633-641
10. 15O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med 2000;44:450-456
11. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47:93-100
12. DuAT, Jahng GH, Hayasaka S, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 2006;67: 1215-1220
13. Johnson NA, Jahng G-H, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005;234:851-859
14. Alsop DC, Casement M, de Bazelaire C, et al. Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage 2008;42:1267-1274
15. Jagust WJ. Neuroimaging in dementia. Neurol Clin 2000;18:885-902
16. Claus JJ, van Harskamp F, Breteler MM, et al. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study. Neurology 1994;44:454-461
17. Powers WJ, Perlmutter JS, Videen TO, et al. Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease. Neurology 1992;42:765-770
18. Lopez OL, Becker JT, Jagust WJ, et al. Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry 2006;77:159-165
19. Kuller LH, Lopez OL, Jagust WJ, et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 2005;64:1548-1552
20. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1:263-276
21. Lopez OL, Kuller LH, Fitzpatrick A, et al. Evaluations of dementia in the Cardiovascular Health Cognition Study. Neuroepidemiology 2003;22:1-12
22. Lopez OL, Jagust WJ, DeKosky ST, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurology 2003;60:1385-1389
23. Dai W, Lopez OL, Carmichael OT, et al. Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250:856-866
24. McKhann G, Drachman DA, Folstein MF, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944
25. Manolio TA, Kronmal RA, Burke GL, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke 1994;25:318-327
26. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22
27. Laurienti PJ, Field AS, Burdette JH, et al. Relationship between caffeine-induced changes in resting cerebral perfusion and blood oxygenation level-dependent signal. AJNR Am J Neuroradiol 2003;24:1607-1611
28. Yue NC, Arnold AM, Longstreth WT, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the Cardiovascular Health Study. Radiology 1997;202:33-39
29. Bryan RN, Wells SW, Miller TJ, et al. Infarctlike lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly - data from the Cardiovascular Health Study. Radiology 1997;202:47-54
30. Bernick C, Kuller L, Dulberg C, et al. Silent MRI infarcts and the risk of future stroke: the Cardiovascular Health Study. Neurology 2001;57:1222-1229
31. Longstreth WT, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. Stroke 1996;27:1274-1282
32. Longstreth WT, Bernick C, Manolio TA, et al. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people. Arch Neurol 1998;55:1217-1225
33. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318
34. Graham JE, Rockwood K, Beattie BL. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349: 1793-1796
35. Alsop DC, Detre JA. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998;208:410-416
36. Gach HM, Dai W. Simple model of double adiabatic inversion (DAI) efficiency. Magn Reson Med 2004;52:941-946
37. Dai W. Advancements in Quantitative Perfusion Magnetic Resonance Imaging (MRI) of Dementia [dissertation]. Pittsburgh: University of Pittsburgh; 2006
38. Buxton RB, Frank LR, Wong EC, et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40:383-396
39. Dai W, Lopez OL, Carmichael OT, et al. Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke 2008;39:349-354
40. Chen M. 3-D Deformable Registration Using a Statistical Atlas with Applications in Medicine [dissertation]. Pittsburgh: Carnegie Mellon University; 1999
41. Meltzer CC, Cantwell MN, Greer PJ, et al. Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. J Nucl Med 2000;41:1842-1848
42. Prince SE, Woo S, Doraiswamy PM, et al. Functional MRI in the early diagnosis of Alzheimer's disease: is it time to refocus? Expert Rev Neurother 2008;8:169-175
43. Bryan RN, Manolio TA, Scertz LD, et al. A method for using MR to evaluate the effects of cardiovascular disease on the brain: the Cardiovascular Health Study. AJNR Am J Neuroradiol 1994;15:1625-1633
44. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259
45. Jack CR, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794
46. Jack CR Jr, Petersen RC, Xu Y, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998;51:993-999
47. Lee C, Lopez OL, Becker JT, et al. Imaging cerebral blood flow in the cognitively normal aging brain with arterial spin labeling: implications for imaging of neurodegenerative disease. J Neuroimaging 2009;19:344-352 Epub 2009 Mar 9
48. Komorita SS. Attitude content, intensity, and the neutral point on a Likert scale. J Soc Psychol 1963;61:327-334
49. Jack CR Jr, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008;131(pt 3):665-680 Epub 2008 Feb 7
50. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174
51. Lopez OL, Kuller LH, Becker JT, et al. Incidence of dementia in mild cognitive impairment in the Cardiovascular Health Study. Arch Neurol 2007;64:416-420
52. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308
53. Roberts DA, Detre JA, Bolinger L, et al. Quantitative magnetic resonance imaging of human brain perfusion at 1.5T using steady state inversion of arterial water. Proc Natl Acad Sci U S A 1994;91:33-37
54. Silverman DH, Gambhir SS, Huang HW, et al. Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. J Nucl Med 2002;43:253-266
55. McNeill R, Sare GM, Manoharan M, et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007;78:350-355
56. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compond-B. Ann Neurol 2004;55:306-319
57. Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005;25:7709-7717
58. Mintun MA, Larossa GN, Sheline YI, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006;67:446-452
59. Deibler AR, Pollock JM, Kraft RA, et al. Arterial spin-labeling in routine clinical practice. Part 2. Hypoperfusion patterns. AJNR Am J Neuroradiol 2008;29:1235-1241
60. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967-972
61. Duara R, Loewenstein DA, Potter E, et al. Medial temporal lobe atrophy on MRIscans and the diagnosis of Alzheimer disease. Neurology 2008;71:1986-1992
62. Aviv RI, Shelef I, Malam S, et al. Early stroke detection and extent: impact of experience and the role of computed tomography angiography source images. Clin Radiol 2007;62:447-452
63. Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group - Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-1674
64. Bozzali M, Cercignani M, Caltagirone C. Brain volumetrics to investigate aging and the principal forms of degenerative cognitive decline: a brief review. Magn Reson Imaging 2008;26:1065-1070
65. Bonte FJ, Weiner MF, Bigio EH, et al. Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients. Radiology 1997;202:793-797